Neovasc develops and manufactures pericardial tissue-based devices for use in cardiac, vascular and general surgery. We work with industry partners around the world to support their programs to commercialize tissue-based medical devices.
Product Details & Video
Using a catheter-based procedure similar to a coronary stent implantation, the Neovasc Reducer™ is a percutaneous treatment for refractory angina, a condition that affects millions worldwide and until now, has been considered untreatable.
Product Details & Video
A transcatheter device that is delivered through the apex of the heart or to replace a malfunctioning native mitral valve, Tiara™ will enable the treatment of mitral regurgitation, a serious condition that affects more than four million patients in the U.S. alone.
Product Details & VideoSite Design by TANAKA CREATIVE.
© 2012 Neovasc Inc.